Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ryu, Wi-Sun | - |
dc.contributor.author | Schellingerhout, Dawid | - |
dc.contributor.author | Hong, Keun-Sik | - |
dc.contributor.author | Jeong, Sang-Wuk | - |
dc.contributor.author | Kim, Beom Joon | - |
dc.contributor.author | Kim, Joon-Tae | - |
dc.contributor.author | Lee, Kyung Bok | - |
dc.contributor.author | Park, Tai Hwan | - |
dc.contributor.author | Park, Sang-Soon | - |
dc.contributor.author | Park, Jong-Moo | - |
dc.contributor.author | Kang, Kyusik | - |
dc.contributor.author | Cho, Yong-Jin | - |
dc.contributor.author | Park, Hong-Kyun | - |
dc.contributor.author | Lee, Byung-Chul | - |
dc.contributor.author | Yu, Kyung-Ho | - |
dc.contributor.author | Oh, Mi Sun | - |
dc.contributor.author | Lee, Soo Joo | - |
dc.contributor.author | Kim, Jae Guk | - |
dc.contributor.author | Cha, Jae-Kwan | - |
dc.contributor.author | Kim, Dae-Hyun | - |
dc.contributor.author | Lee, Jun | - |
dc.contributor.author | Han, Moon-Ku | - |
dc.contributor.author | Park, Man Seok | - |
dc.contributor.author | Choi, Kang-Ho | - |
dc.contributor.author | Nahrendorf, Matthias | - |
dc.contributor.author | Lee, Juneyoung | - |
dc.contributor.author | Bae, Hee-Joon | - |
dc.contributor.author | Kim, Dong-Eog | - |
dc.date.accessioned | 2022-02-15T21:42:12Z | - |
dc.date.available | 2022-02-15T21:42:12Z | - |
dc.date.created | 2022-02-08 | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 0364-5134 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/135907 | - |
dc.description.abstract | Objective: We investigated (1) the associations between pre-stroke aspirin use and thrombus burden, infarct volume, hemorrhagic transformation, early neurological deterioration (END), and functional outcome, and (2) whether stroke subtypes modify these associations in first-ever ischemic stroke. Methods: This multicenter magnetic resonance imaging (MRI)-based study included 5,700 consecutive patients with acute first-ever ischemic stroke, who did not undergo intravenous thrombolysis or endovascular thrombectomy, from May 2011 through February 2014. Propensity score-based augmented inverse probability weighting was performed to estimate adjusted effects of pre-stroke aspirin use. Results: The mean age was 67 years (41% women), and 15.9% (n = 907) were taking aspirin before stroke. Pre-stroke aspirin use (vs nonuse) was significantly related to a reduced infarct volume (by 30%), particularly in large artery atherosclerosis stroke (by 45%). In cardioembolic stroke, pre-stroke aspirin use was associated with a similar to 50% lower incidence of END (adjusted difference = -5.4%, 95% confidence interval [CI] = -8.9 to -1.9). Thus, pre-stroke aspirin use was associated with similar to 30% higher likelihood of favorable outcome (3-month modified Rankin Scale score < 3), particularly in large artery atherosclerosis stroke and cardioembolic stroke (adjusted difference = 7.2%, 95% CI = 1.8 to 12.5 and adjusted difference = 6.4%, 95% CI = 1.7 to 11.1, respectively). Pre-stroke aspirin use (vs nonuse) was associated with 85% less frequent cerebral thrombus-related susceptibility vessel sign (SVS) in large artery atherosclerosis stroke (adjusted difference = -1.4%, 95% CI = -2.1 to -0.8, p < 0.001) and was associated with similar to 40% lower SVS volumes, particularly in cardioembolic stroke (adjusted difference = -0.16 cm(3), 95% CI = -0.29 to -0.02, p = 0.03). Moreover, pre-stroke aspirin use was not significantly associated with hemorrhagic transformation (adjusted difference = -1.1%, p = 0.09). Interpretation :Pre-stroke aspirin use associates with improved functional independence in patients with first-ever ischemic large arterial stroke by reducing infarct volume and/or END, likely by decreasing thrombus burden, without increased risk of hemorrhagic transformation. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | ACUTE ISCHEMIC-STROKE | - |
dc.subject | HEMORRHAGIC TRANSFORMATION | - |
dc.subject | SEVERITY | - |
dc.subject | THROMBECTOMY | - |
dc.subject | LEUKOARAIOSIS | - |
dc.subject | SUSCEPTIBILITY | - |
dc.subject | RESISTANCE | - |
dc.subject | REGISTRY | - |
dc.subject | SUBTYPE | - |
dc.subject | GROWTH | - |
dc.title | Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Juneyoung | - |
dc.identifier.doi | 10.1002/ana.26219 | - |
dc.identifier.scopusid | 2-s2.0-85116381500 | - |
dc.identifier.wosid | 000703626200001 | - |
dc.identifier.bibliographicCitation | ANNALS OF NEUROLOGY, v.90, no.5, pp.763 - 776 | - |
dc.relation.isPartOf | ANNALS OF NEUROLOGY | - |
dc.citation.title | ANNALS OF NEUROLOGY | - |
dc.citation.volume | 90 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 763 | - |
dc.citation.endPage | 776 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | ACUTE ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | HEMORRHAGIC TRANSFORMATION | - |
dc.subject.keywordPlus | LEUKOARAIOSIS | - |
dc.subject.keywordPlus | REGISTRY | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordPlus | SUBTYPE | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | THROMBECTOMY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.